CVE-2015-3459

highEPSS 0.051 · 92. PerzentilEURUUS
grimoire priorityP2 · Scheduled
Exploitable?
—
no known exploitation
Likely / severe?
5.06% (92nd) EPSS
CVSS 10 · high
Is it mine?
7 products
Prüfe deine Angriffsfläche
Who says so?
5 sources
cnnvd · enisa_euvd · fstec_bdu · cisa_csaf_ot

EPSS · bewertet 2026-10-20

The communication module on the Hospira LifeCare PCA Infusion System before 7.0 does not require authentication for root TELNET sessions, which allows remote attackers to modify the pump configuration via unspecified commands.

01

Behebungen

Hersteller-Fix, Mitigation oder Workaround, wie von den Quellen veröffentlicht.

Noch kein Hersteller-Fix; eine Mitigation ist verfügbar.

  • MitigationLifeCare PCA Infusion Systemcisa_csaf_ot

    CS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access. Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira’s Version 7.0 is being reviewed by the FDA prior to its release. The release date for Version 7.0 of the LifeCare PCA Infusion System has not been determined. For additional information about Hospira’s new release, contact Hospira’s technical support at 1‑800-241-4002. ICS-CERT encourages asset owners to take defensive measures to protect against this and other cybersecurity risks.

  • MitigationLifeCare PCA Infusion Systemcisa_csaf_ot

    Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira will be retiring older versions of the LifeCare PCA Infusion System, Versions 2 and Versions 3, by the end of the year, 2015.

02

cvss

Technischer Schweregrad, 0–10. Eine Zeile je Quelle.

10.0
010

Basiswert 0–10 · höher = schwerwiegender · Vektor überfahren zum Auflösen⚠ Quellen uneinig · high–critical · 8.5–10

v2.010highAV:N/AC:L/Au:N/C:C/I:C/A:Cprimary · NVD / NIST USAusnutzbarkeit 10 · Auswirkung 10
v2.010criticalAV:N/AC:L/Au:N/C:C/I:C/A:Csecondary · CISA US
v2.010criticalAV:N/AC:L/Au:N/C:C/I:C/A:Csecondary · FSTEC (BDU) RU
v2.08.5highAV:N/AC:L/Au:N/C:C/I:C/A:C/E:Usecondary · CVSS-BT (t0sche)
03

schwächen

Die CWE-Schwächeklassen, zu denen dies gehört.

04

betroffene Produkte (7)

Betroffene Produkte und Versionsbereiche.

05

Advisories (2)

Hersteller- und Ökosystem-Meldungen dazu.

  • ICSA-15-125-01Hospira LifeCare PCA Infusion System Vulnerabilities2015-02-05icsa · cisa_csaf_otUS

    This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

  • ICSA-15-125-01BHospira LifeCare PCA Infusion System Vulnerabilities2015-02-05icsa · cisa_csaf_otUS

    This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

06

auch bekannt als (4)

Weitere Namen und Kennungen dieser Entität.

07

quellen

Welche Quellen diesen Datensatz belegen und wann.

veröffentlicht 2015-04-29geändert 2026-06-17
09

Referenzen (21)

Externe Belege — Patches, Meldungen, Analysen.

scry

Angreifer nutzen Schwachstellen wie diese gegen im Internet exponierte Dienste aus. Sehen Sie mit einem kostenlosen Passiv-Scan, was exponiert ist.

Kostenloser Scan